Loading organizations...
§ Private Profile · London, England, United Kingdom
Therapeutics company
R1 Therapeutics has raised $775.0M across 1 funding round.
R1 Therapeutics has raised $775.0M in total across 1 funding round.
R1 Therapeutics has raised $775.0M in total across 1 funding round.
R1 Therapeutics's investors include Abingworth, DaVita Venture Group, F-Prime Capital, Curie.Bio, SymBiosis, U.S. Renal Care.
R1 Therapeutics has raised $775.0M across 1 funding round. Most recently, it raised $775.0M Series A in March 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 17, 2026 | $775M Series A | Abingworth, Davita Venture Group, F Prime Capital | Curie.bio, SymBiosis, U.S. Renal Care | Announced |